EODData

NASDAQ, IKT: Inhibikase Therapeutics Inc

02 Apr 26 15:59
LAST:

1.795

CHANGE:
 0.01
OPEN:
1.810
HIGH:
1.830
ASK:
0.000
VOLUME:
573.6K
CHG(%):
0.55
PREV:
1.810
LOW:
1.730
BID:
0.000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Apr 261.7401.8301.7301.800759.8K
01 Apr 261.7101.8301.7001.8101.17M
31 Mar 261.6201.6901.5901.680648.5K
30 Mar 261.6901.6901.5701.580897.3K
27 Mar 261.6501.7601.6201.680762.9K
26 Mar 261.6101.6851.6101.630551.6K
25 Mar 261.6001.7001.6001.6301.13M
24 Mar 261.7201.7301.5701.6006.31M
23 Mar 261.8201.8561.7001.7401.09M
20 Mar 261.8401.8751.7751.8008.87M

PROFILE

Name:Inhibikase Therapeutics Inc
About:Inhibikase Therapeutics, Inc. operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson's disease and related disorders. Its lead product candidate is IkT-148009, a non-receptor Abelson tyrosine kinase inhibitor, which is in Phase 2a clinical trials to the treatment of Parkinson's disease and gastrointestinal tract. The company is also developing IkT-001Pro, a prodrug of the anticancer agent imatinib mesylate to treat stable phase chronic myelogenous leukemia. Inhibikase Therapeutics, Inc. has research and development collaborations with Johns Hopkins University, Arizona State University, and Michigan State University; and a collaborative research and development agreement with Sphaera Pharma Pte. Ltd. The company was founded in 2008 and is based in Atlanta, Georgia.
Sector:Healthcare
Industry:Biotechnology
Address:3350 Riverwood Parkway SE, Atlanta, GA, United States, 30339
Website:https://www.inhibikase.com
CUSIP:45719W106
CIK:0001750149
ISIN:US45719W2052
FIGI:BBG005TP2339

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:4.20 
Forward P/E:-7.56 
Price to Book:2.34 
EPS Ratio:0.45 
Shares:121.27M 
Market Cap:217.67M 

TECHNICAL INDICATORS

MA5:1.715.0%
MA10:1.705.9%
MA20:1.811.1%
MA50:1.781.0%
MA100:1.714.9%
MA200:1.705.6%
STO9:79.59
STO14:45.83
RSI14:37.80 
WPR14:-45.00
MTM14:-0.18
ROC14:-0.09 
ATR:0.12 
Week High:1.831.9%
Week Low:1.5714.3%
Month High:2.0815.9%
Month Low:1.575.6%
Year High:2.3731.8%
Year Low:1.3335.0%
Volatility:46.83 

RECENT SPLITS

Date Ratio
30 Jun 20231-6